Clinical Trials
15 trialsNCT05263947 2026-02-24
Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT02264210 2024-09-25
CORIN
Sun Yat-sen University
Phase 2 Completed
NCT02044328 2022-02-08
ICAPE
Betta Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT02934256 2021-09-09
Icotinib
Beijing Tiantan Hospital
Phase 2 Completed
NCT03736837 2021-03-15
ALTER-L004
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT02744664 2020-05-27
Cryotherapy Combine Icotinib for Advanced NSCLC Treatment
Fuda Cancer Hospital, Guangzhou
Phase 4 Completed
NCT01855854 2019-07-05
Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH
Betta Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT02889692 2019-04-11
Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma
Shanghai University of Traditional Chinese Medicine
Phase 3 Completed
NCT01534585 2018-04-17
Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Taizhou Hospital
Phase 1/2 Completed
NCT01724801 2017-03-01
BRAIN
Guangdong Association of Clinical Trials
Phase 3 Completed
NCT02486354 2015-07-01
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy
Betta Pharmaceuticals Co., Ltd.
Phase 3 Completed
NCT01514877 2014-07-23
Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer
Zhejiang Cancer Hospital
Phase 2 Completed
NCT01465243 2014-02-17
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose
Betta Pharmaceuticals Co., Ltd.
Phase 4 Completed
NCT01516983 2014-02-17
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 1/2 Completed
NCT01040780 2014-02-14
ICOGEN
Betta Pharmaceuticals Co., Ltd.
Phase 3 Completed